Moroxite F

Lund, Sweden Founded: 2021 • Age: 5 yrs
Regenerative medicine for fracture fixation in osteoporotic bone is developed.
Annual revenue - Latest available
Total funding $1.1M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 5 Brand Intelligence

About Moroxite F

Moroxite F is a company based in Lund (Sweden) founded in 2021. Moroxite F has raised $1.06 million across 1 funding round from investors including Almi and Fåhraeus Startup and Growth Fund. Moroxite F offers products and services including Xerafuse and Xerafill. Moroxite F operates in a competitive market with competitors including Nanovis, FLUIDINOVA, Masi-Epoxi and Ceramat, among others.

  • Headquarter Lund, Sweden
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Moroxite Ab
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.06 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.06 M (USD), Seed

    Jun 01, 2022

  • Investors
    Almi

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Moroxite F

Moroxite F offers a comprehensive portfolio of products and services, including Xerafuse and Xerafill.

Product name locked
Category locked
Primary

Ceramic granule for spinal fusion with BMP-2.

Product name locked
Category locked
Locked

Injectable for fracture fixation to improve screw anchorage.

People of Moroxite F

Headcount 1-10
Employee Profiles 8
Employee Profiles
People
Deepak Raina
Chief Technical Officer
People
Anna Szilágyi
Director Design And Development
People
Apurva Kaul
Administrator
People
Carin Nilsson Thorell
Quality Assurance Head

Unlock access to complete

Funding Insights of Moroxite F

Moroxite F has successfully raised a total of $1.06M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.06 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Moroxite F

Moroxite F has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Almi and Fåhraeus Startup and Growth Fund.

All
Venture Fund
Investor Description Founded Year Domain Location
Investments are provided by Almi in seed to growth-stage startups.
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for Moroxite F

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Moroxite F

Investments
Premium access

Investment portfolio details for Moroxite F

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Moroxite F

Premium access

Detailed financials for Moroxite F

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Moroxite F Comparisons

Moroxite F Primary company
Description
Regenerative medicine for fracture fixation in osteoporotic ...
Location
Lund, Sweden
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Moroxite F

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Moroxite F

Moroxite F operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanovis, FLUIDINOVA, Masi-Epoxi and Ceramat, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Nano-technology-based spinal implants are manufactured by Nanovis.
Locked Locked Locked
Synthetic nano-hydroxyapatite materials are manufactured and supplied.
Locked Locked Locked
Limited information available
Locked Locked Locked
Advanced ceramic materials for bone replacement are developed and provided.
Premium access

Detailed competitors of Moroxite F

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Moroxite F

Premium access

Complete news archive for Moroxite F

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Moroxite F

Moroxite F was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Moroxite F is headquartered in Lund, Sweden.

Johan Tinnerholm is the current CEO of Moroxite F.

Moroxite F is a funded company, having raised a total of $1.06M across 1 funding round to date.

Moroxite F was founded in 2021 in Lund, Sweden, within the regenerative medicine sector. A fracture fixation device is being developed to deliver hydroxyapatite particles at the bone-implant interface. Enhanced anchorage in osteoporotic bone is targeted through this approach. Operations center on advancing implant technologies for orthopedic applications, with a focus on clinical viability and regulatory compliance in Europe.

Moroxite F's top competitors include Nanovis, FLUIDINOVA and Ceramat.

Moroxite F offers Xerafuse and Xerafill.

Moroxite F has 2 investors. Key investors include Almi, and Fåhraeus Startup and Growth Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available